Zhanyu Pan

机构：University of Tsukuba, Xuzhou Medical College, Tianjin Medical University Cancer Institute and Hospital, Guangzhou Medical University · ORCID：0000-0001-7709-2941

发表论文 33 篇 · 总被引 257 次 · h-index 9

代表论文

• Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma (2024 · APOPTOSIS · 被引 34)
• Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma (2020 · Cancer Gene Therapy · 被引 32)
• Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study (2023 · BMC Cancer · 被引 28)
• MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells (2022 · Journal of Oncology · 被引 24)
• Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: A real- world study (2022 · Research Square · 被引 13)
• From complexity to clarity: development of CHM-FIEFP for predicting effective components in Chinese herbal formulas by using big data (2024 · Cancer Biology and Medicine · 被引 7)